Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP737289.RAJdHG4FCCgluxKRMcbC0I5aCNrTsUW0gijFOzvfzhx3Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP737289.RAJdHG4FCCgluxKRMcbC0I5aCNrTsUW0gijFOzvfzhx3Y130_assertion type Assertion NP737289.RAJdHG4FCCgluxKRMcbC0I5aCNrTsUW0gijFOzvfzhx3Y130_head.
- NP737289.RAJdHG4FCCgluxKRMcbC0I5aCNrTsUW0gijFOzvfzhx3Y130_assertion wasGeneratedBy ECO_0000203 NP737289.RAJdHG4FCCgluxKRMcbC0I5aCNrTsUW0gijFOzvfzhx3Y130_provenance.
- NP737289.RAJdHG4FCCgluxKRMcbC0I5aCNrTsUW0gijFOzvfzhx3Y130_assertion wasDerivedFrom befree-2016 NP737289.RAJdHG4FCCgluxKRMcbC0I5aCNrTsUW0gijFOzvfzhx3Y130_provenance.
- NP737289.RAJdHG4FCCgluxKRMcbC0I5aCNrTsUW0gijFOzvfzhx3Y130_assertion SIO_000772 19423729 NP737289.RAJdHG4FCCgluxKRMcbC0I5aCNrTsUW0gijFOzvfzhx3Y130_provenance.
- NP737289.RAJdHG4FCCgluxKRMcbC0I5aCNrTsUW0gijFOzvfzhx3Y130_assertion evidence source_evidence_literature NP737289.RAJdHG4FCCgluxKRMcbC0I5aCNrTsUW0gijFOzvfzhx3Y130_provenance.
- NP737289.RAJdHG4FCCgluxKRMcbC0I5aCNrTsUW0gijFOzvfzhx3Y130_assertion description "[Our findings improve current understanding of the biology of IGF-IR and NPM-ALK and have significant therapeutic implications as they identify IGF-IR signaling as a potential therapeutic target in ALK(+) ALCL and possibly other types of malignant lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP737289.RAJdHG4FCCgluxKRMcbC0I5aCNrTsUW0gijFOzvfzhx3Y130_provenance.